Skip to results
Modify your search
NARROW
1-13 of 13
Authors: Thomas Vanassche
Sort by
Journal Article
Prediction of coronary artery disease using urinary proteomics
Dongmei Wei and others
European Journal of Preventive Cardiology, Volume 30, Issue 14, October 2023, Pages 1537–1546, https://doi.org/10.1093/eurjpc/zwad087
Published: 21 March 2023
Journal Article
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial
John W Eikelboom and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 8, December 2022, Pages 786–795, https://doi.org/10.1093/ehjcvp/pvac023
Published: 06 April 2022
Journal Article
The value and limitations of new oral anticoagulant plasma level assessments
Lorenz Van der Linden and others
European Heart Journal Supplements, Volume 24, Issue Supplement_A, February 2022, Pages A32–A41, https://doi.org/10.1093/eurheartj/suab153
Published: 14 February 2022
Journal Article
Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial
Thomas Vanassche and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 5, September 2022, Pages 462–473, https://doi.org/10.1093/ehjcvp/pvab050
Published: 30 June 2021
Journal Article
Corrigendum to: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel and others
in
EP Europace
EP Europace, Volume 23, Issue 10, October 2021, Page 1676, https://doi.org/10.1093/europace/euab157
Published: 28 June 2021
Journal Article
OFFICIAL STATEMENT
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Jan Steffel and others
in
EP Europace
EP Europace, Volume 23, Issue 10, October 2021, Pages 1612–1676, https://doi.org/10.1093/europace/euab065
Published: 25 April 2021
Journal Article
Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial
Thomas Vanassche and others
European Journal of Preventive Cardiology, Volume 27, Issue 3, 1 February 2020, Pages 296–307, https://doi.org/10.1177/2047487319882154
Published: 29 August 2020
Journal Article
Interplay of cardiac remodelling and myocardial stiffness in hypertensive heart disease: a shear wave imaging study using high-frame rate echocardiography
Get access
Marta Cvijic and others
European Heart Journal - Cardiovascular Imaging, Volume 21, Issue 6, June 2020, Pages 664–672, https://doi.org/10.1093/ehjci/jez205
Published: 03 August 2019
Journal Article
Staphylococcus aureus endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves
Laurens Liesenborghs and others
European Heart Journal, Volume 40, Issue 39, 14 October 2019, Pages 3248–3259, https://doi.org/10.1093/eurheartj/ehz175
Published: 03 April 2019
Journal Article
Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES
Get access
Thomas Vanassche and others
European Heart Journal, Volume 36, Issue 5, 1 February 2015, Pages 281–288, https://doi.org/10.1093/eurheartj/ehu307
Published: 03 September 2014
Journal Article
Heparin bridging in peri-procedural management of new oral anticoagulant: a bridge too far?
Get access
Thomas Vanassche and others
European Heart Journal, Volume 35, Issue 28, 21 July 2014, Pages 1831–1833, https://doi.org/10.1093/eurheartj/ehu034
Published: 18 February 2014
Chapter
The NOACs: pharmacodynamics and pharmacokinetics
Get access
Thomas Vanassche and others
Published: 01 July 2018
Updated: 31 January 2022
Chapter
Treatment: haemodynamic and respiratory support
Get access
Thomas Vanassche and Peter Verhamme
Published: 01 July 2018